|
⚲
|
| Keyboard |
| Sapir Alex
✚
|
|
|---|---|
| CIK # | 0001709415 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001709415] | |
| 4 | [0001709415] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sapir Alex | |
| Fulcrum Therapeutics Inc | |
| PhaseBio Pharmaceuticals Inc | |
| Dova Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fulcrum Therapeutics Inc FULC
Stock option - Right to Buy · derivative
|
2026-02-02 | Grant | 650,000 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Stock option - Right to Buy · derivative
|
2025-01-24 | Grant | 582,000 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Stock option - Right to Buy · derivative
|
2024-07-03 | Option exercise | 150,000 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Common Stock
|
2024-07-03 | Option exercise | 150,000 | $3.27 | 490,500 |
|
Fulcrum Therapeutics Inc FULC
Common Stock
|
2024-03-04 | Buy | 43,360 | $11.35 | 492,136 |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 3,750 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Non-employee Director Stock Option (right to buy) · derivative
|
2022-05-19 | Grant | 17,500 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2022-05-19 | Grant | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Non-employee Director Stock Option (right to buy) · derivative
|
2021-06-03 | Grant | 14,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Non-employee Director Stock Option (right to buy) · derivative
|
2020-06-03 | Grant | 4,909 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 32,000 | $0.00 | |
|
Dova Pharmaceuticals Inc DOVA
Common Stock
|
2018-08-14 | Buy | 21,700 | $22.83 | 495,411 |
|
Dova Pharmaceuticals Inc DOVA
Common Stock
|
2017-12-22 | Option exercise | 26,809 | $3.73 | 99,998 |
|
Dova Pharmaceuticals Inc DOVA
Employee Stock Option (Right to Buy) · derivative
|
2017-12-22 | Option exercise | 26,809 | $0.00 | |
|
Dova Pharmaceuticals Inc DOVA
Common Stock
|
2017-07-05 | Buy | 20,100 | $17.00 | 341,700 |